Close Menu

NEW YORK (360Dx) – Israeli in vitro diagnostics firm Todos Medical today announced a distribution deal with Orot+ for Todos' TM-B2 blood tests for breast cancer screening in Romania and Austria.

Orto+, headquartered in Tel Aviv, Israel will be responsible for the costs of marketing and distributing TM-B2. Todos will use data from the commercialization efforts to support further development and commercialization of the test in other geographies, it said. Additional terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.